XIIlab Co.,Ltd Statistics
Total Valuation
XIIlab Co.,Ltd has a market cap or net worth of KRW 42.65 billion. The enterprise value is 34.46 billion.
Market Cap | 42.65B |
Enterprise Value | 34.46B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
XIIlab Co.,Ltd has 6.09 million shares outstanding. The number of shares has increased by 0.73% in one year.
Shares Outstanding | 6.09M |
Shares Change (YoY) | +0.73% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 47.30% |
Owned by Institutions (%) | n/a |
Float | 3.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.47 |
PB Ratio | 3.86 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.88 |
EV / Sales | 6.04 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.75 |
Financial Position
The company has a current ratio of 7.27, with a Debt / Equity ratio of 0.12.
Current Ratio | 7.27 |
Quick Ratio | 6.91 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | -0.23 |
Interest Coverage | -74.24 |
Financial Efficiency
Return on equity (ROE) is -48.20% and return on invested capital (ROIC) is -27.80%.
Return on Equity (ROE) | -48.20% |
Return on Assets (ROA) | -25.63% |
Return on Capital (ROIC) | -27.80% |
Revenue Per Employee | 75.09M |
Profits Per Employee | -92.98M |
Employee Count | 76 |
Asset Turnover | 0.32 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.56% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -46.56% |
50-Day Moving Average | 7,305.80 |
200-Day Moving Average | 10,419.30 |
Relative Strength Index (RSI) | 48.47 |
Average Volume (20 Days) | 180,358 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XIIlab Co.,Ltd had revenue of KRW 5.71 billion and -7.07 billion in losses. Loss per share was -1,160.30.
Revenue | 5.71B |
Gross Profit | 281.44M |
Operating Income | -7.26B |
Pretax Income | -7.07B |
Net Income | -7.07B |
EBITDA | -6.05B |
EBIT | -7.26B |
Loss Per Share | -1,160.30 |
Balance Sheet
The company has 9.56 billion in cash and 1.36 billion in debt, giving a net cash position of 8.19 billion or 1,344.42 per share.
Cash & Cash Equivalents | 9.56B |
Total Debt | 1.36B |
Net Cash | 8.19B |
Net Cash Per Share | 1,344.42 |
Equity (Book Value) | 11.06B |
Book Value Per Share | 1,815.41 |
Working Capital | 8.86B |
Cash Flow
In the last 12 months, operating cash flow was -5.62 billion and capital expenditures -372.80 million, giving a free cash flow of -5.99 billion.
Operating Cash Flow | -5.62B |
Capital Expenditures | -372.80M |
Free Cash Flow | -5.99B |
FCF Per Share | -983.95 |
Margins
Gross margin is 4.93%, with operating and profit margins of -127.14% and -123.82%.
Gross Margin | 4.93% |
Operating Margin | -127.14% |
Pretax Margin | -123.82% |
Profit Margin | -123.82% |
EBITDA Margin | -106.02% |
EBIT Margin | -127.14% |
FCF Margin | -105.04% |
Dividends & Yields
XIIlab Co.,Ltd does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.73% |
Shareholder Yield | -0.73% |
Earnings Yield | -16.58% |
FCF Yield | -14.06% |
Stock Splits
The last stock split was on September 15, 2021. It was a forward split with a ratio of 2.
Last Split Date | Sep 15, 2021 |
Split Type | Forward |
Split Ratio | 2 |
Scores
XIIlab Co.,Ltd has an Altman Z-Score of 13.55.
Altman Z-Score | 13.55 |
Piotroski F-Score | n/a |